Mendelian susceptibility to mycobacterial disease (MSMD) is an inherited predisposition to infections by Bacille-Calmette Guérin (BCG) vaccine or by environmental mycobacteria. The etiology of MSMD has been associated with up to nineteen different genetic mutations in interferon (IFN)-γ-related genes. 1 Although mycobacteria susceptibility-associated genetic mutations are rare in the population, their diagnosis is crucial for an efficient and timely treatment. Kong et al. 2 have recently described an autosomal recessive deficiency in the signal peptidase-like 2 A (SPPL2-a) as a new genetic etiology for MSMD in three patients that had suffered BCG dissemination disease.
Such congenital genetic alterations were shown to be located at the IFN-γ-related genes machinery, herein being a key system of the host immune response against mycobacteria infections. Upon recognition of mycobacteria-derived molecules, antigenpresenting cells (APCs) produce interleukin (IL)-23 (composed by IL-12p40 and IL-23p19) and IL-18 ( Fig. 1) . 4 Such cytokines promote the secretion of IFN-γ by T cells and natural killer cells (NK), which binds to the IFN receptor (IFNGR1 and IFNGR2) on the surface of dendritic cells (DCs) and macrophages. 4 Also, the Janus-associated kinase (JAK) and the general to signal transducer and activator transcription (STAT) are bound to IFN receptor complex to induce the expression of genes, such as the interferon-stimulated gene (ISG), tumour necrosis factor (TNF) and the Interferon regulatory factor (IRF)-8 ( Fig. 1) . The expression of IRF8 induces the activation of the APCs, inducing viral clearance. 5 In the patients with partial IRF8 deficiency, the activation of APCs is impaired. 5 Therefore, MSMD can result from genetic deficiencies that impair the molecular machinery responsible of activating the IFN-γ response. Importantly, genetic deficiencies associated to MSMD have also been previously reported for the following genes: IL12B, IL12RB1, IRF8, ISG15 (Interferon-stimulated gene 15), NEMO, IFNGR1, IFNGR2, STAT1, IRF8, CYBB and TYK2.
1 Those genetic mutations have been reported to cause susceptibility not only to mycobacteria infections, but also to infection by other pathogen, in addition to several pleiotropic alterations on function of the host immune system. SPPL2-a encodes for a transmembrane protease required for the cleavage of the N-terminal fragment (NTF) of a transmembrane glycoprotein (CD74) in the endosome. CD74 binds to the major histocompatibility complex (MHC) class II in the endoplasmic reticulum ( Fig. 1) . 6 Upon the cleavage of CD74, proteolytic degradation takes place and the intracellular domain of the NTF CD74 is degraded. Importantly, Casanova and colleagues showed that an SPPL2-a deficiency causes the accumulation of CD74 in B cells and monocytes from patients. This phenotype was reproduced by the treatment of leucocytes derived from healthy donors with SPPL2a inhibitors, also triggered the accumulation of CD74 in mainly HLA Class II + APCs, including B cells and DCs. 2 As SPPL2a is required for B cell development, 7 authors evaluated whether the B cell response was altered in SPPL2a-deficient patients. 2 Importantly, no significant B cell deficiency was evidenced in any of these patients, as compared to healthy controls. In this latter study, two out of three patients were twins, which when vaccinated with BCG at birth displayed inflammation at axillary lymph nodes. 2 The remaining patient was vaccinated at 2 months of age and presented a left axillary lymphadenopathy. 2 It is worth to mention that the majority of the worldwide population is currently vaccinated with the BCG to prevent from Tuberculosis 8 and that several recombinant BCGs are under development to prevent from viral infections with promising results. [9] [10] [11] One of the most important findings of the work by Kong et al. was the significant decrease shown by SPPL2a-deficient patients of type 2 myeloid conventional dendritic cells (cDC2s) and also, but to lesser extend, of the type I DCs (cDC1s). On the contrary, no significant differences were observed for the plasmacytoid dendritic cell (pDCs) population between SPPL2a-deficient patients and healthy controls. DC deficiency syndromes have been previously reported in primary immunodeficiency disease and associated to mutations in the IRF8 gene, among others. 12 Kong et al. found that IRF-8-deficient donors presented lower frequency of both, cDC1s and cDC2s, but equivalent numbers of pDCs as compared to healthy controls. Precursors of human DCs derive from hematopoietic stems cells in the bone marrow. 13 Differentiation from such precursor cells, leads to the generation of either myeloid dendritic cells (cDC1 or cDC2), as well as pDCs. 14, 15 To evaluate whether the defect on DCs was at the preDCs stage, DCs were differentiated by purifying CD34 + cells from cord blood healthy donors and by adding cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF). Further, when SPPL2 inhibitors were added to those cord bloodderived DCs accumulation of CD74 was observed in the cDC2 population. 2 Consistently with this notion, the frequency of pDCs and cDC2 was reduced in untreated Tuberculosis patients 16 and impaired frequency and functionality of DCs has been previously reported for MSMD patients with a IRF-8 deficiency. 12 Importantly, Kong et al. also evaluated whether the SPPL2a deficiency affected IL12p40 production, due to the low frequency of the cDC2 population, however, no significant differences were observed as compared to healthy controls. This observation is important because mutations in the IL12B gene in MSMD patients lead to undetectable levels of IL-12p40. 17 Furthermore, the absence of IL-12p40 has been related to an increased susceptibility not only to mycobacterial but also to Salmonella infections. 18 The impairment of DC function found by Kong et al.
2 might reduce T cell priming upon an exposure to a pathogen, thereby promoting an enhanced susceptibility to dissemination of microbes, such as mycobacteria. Therefore, the next question was as to whether the decrease on DCs numbers shown by those patients with SPPL2a deficiency could also impair T cell priming and cytokine production. Therefore, authors evaluated whether patients showed impairment in the T cell polarization ability by culturing naïve T cells from those patients with T cell activation and expansion (TAE) beads, under various polarizing conditions (Th1, Th2 or Th17). Importantly, neither SPPL2a-nor IRF-8-deficient patients showed a change in the T cell polarizing ability. However, when polarization of memory T cells was evaluated, IRF-8-deficient patients displayed a deficiency in the CD4 + T cell polarizing ability as compared to healthy donors. 2 Furthermore, IRF-8 has been . APCs can also recognize the bacteria through receptors such as scavenger receptors (SR), mannose receptors (MR) and complement receptors (CR), which triggers the formation of the phagosome 25 (3) . The phagosome then fuses with a lysosome and forms the phagolysosome, where bacteria are degraded (4). Intracellular receptors recognize peptides from the degraded bacteria, which also triggers the activation of the NF-κB pathway and cytokines secretion 25 (2) . The MHC-II formed is associated with the CD74 protein in the endoplasmic reticulum and transported to the endosomal compartment (5) . The luminal domain of CD74 is degraded and the MHC-II is loaded with the peptide. Upon MHC-II loading with peptide, CD74 is cleavage by the SPPL2a protein and intracellular domain of N-terminal fragment (NTF) CD74 is released into the cytoplasm. Such cleavage is required for the recycling of the NTF CD74. 6 In the patients with complete SPPL2a deficiency, the NTF accumulates in the membrane of endosome vesicles, impairing the MHC-II processing. 2 Finally, the loaded MHC-II is located to the surface cell and presented to the TCR from the T cell (6) . Furthermore, cytokines secreted by DCs are recognized by T cell (7), which triggers the expression of pro-inflammatory cytokines, such as IL-2 and IFN-γ (8). The secreted IFN-γ binds to receptors on the surface of DCs and macrophages. Upon recognition, the binding of JAK/STAT to the IFN-γ receptor (IFNGR) induces the expression of several genes including ISG, IRF8 and TNF-α 4 (9) . Finally, such signals are important in the APCs activation and other mycobacteria immune response events such as the formation of the granuloma 23 (10) Insights on the crosstalk between dendritic cells and helper T cells in. . . E Rey-Jurado et al.
shown to be expressed by regulatory (Treg) and helper (Th1) T cells, because IRF8-deficient Treg cells presented reduced expression of the chemokine receptor required for a Th1 response, the chemokine C-X-C motif receptor 3 (CXCR3). 19 Importantly, the reduction found for the polarization of CD4 + T cells could affect to the recruitment of CD8 + effector T cells to infected tissues. 20 The understanding of the function of those memory T cell populations could contribute to the design of new vaccines and therapies against Tuberculosis or mycobacteria-caused diseases.
To further study the memory T cell responses in those SPPL2a-deficient patients, the BCG and M. tuberculosis-specific memory T cell responses were evaluated. 2 In this work, authors defined memory T cells as CD4 + CCR6 + T cells. 2 The CCR6 was only expressed by experienced memory T cells and CD4 + CCR6 + T cells displayed both effector and memory phenotypes. 21 Importantly, they found that such memory T cell population from SSPL2a-and IRF8-deficient donors showed an impaired IFN-γ production in response to both BCG and M. tuberculosis antigens, as compared to healthy controls. 2 These molecular alterations altogether lead to a breakdown in the crosstalk between DCs and T cells in response to mycobacterial antigens in SPPL2a-deficient patients, and consequently, cause a defective host immune response against mycobacteria infection. Therefore, these novel results have revealed that SPPL2a plays an important role in the polarization of memory T cells. 2 Due to the increased susceptibility to mycobacterial infections observed in those patients, they corroborated the effect of SPPL2a deficiency on the susceptibility to BCG and Tuberculosis infections in mice. To address that aim, authors challenged SPPL2a-deficient mice with BCG or M. tuberculosis. Remarkably, they found decreased cDC2, low IFN-γ production, increased cell infiltration, decreased percentages of IFN-γ-producing CD4 + and CD8 + T cells, increased colony forming units (CFU) of BCG and reduced survival for SPPL2-a-deficient mice as compared to wildtype controls. 2 Similarly, higher M. tuberculosis CFU, increased infiltration of neutrophils, monocytes and macrophages were found in SPPL2a-deficient mice as compared to wild-type animals.
2 Therefore, these results in mice support the notion that a SPPL2a deficiency leads to a significantly increased susceptibility to mycobacterial infections, including BCG and M. tuberculosis.
2
Conversely to the observed in BCG infection, higher IFN-γ, IL12p40 and TNF-α production were found in SPPL2a-deficient as compared to wild-type mice in response to M. tuberculosis infection. 2 Interestingly, although the production of those proinflammatory cytokines was increased in response to M. tuberculosis in those animals, the infection was not resolved. Such results could be related with the fact that a rapid IFN-γ response might not be enough to resolve the infection and that the bacterial load could be a critical point for the induction of the IFN-γ response. 22 Indeed, the formation of the granuloma in the M. tuberculosis infection could also be involved during the immune response triggered by the pathogen in SPPL2a-deficient mice. It is worth to mention that such an increase of bacterial loads might be related with an important intracellular growth of M. tuberculosis inside macrophages harbored in the granuloma, a structure that is promoted by an increased production IFN-γ and TNF-α. 23 Importantly, it has been previously reported that IRF8-deficiency determines the immune cells recruitment in granuloma during Tuberculosis. 24 Along these lines, it would be interesting to further study the growth of the bacteria and as to how the granuloma structure could be affected in SPPL2a-deficient patients. Herein, these data open a new research branch for the elucidation of novel mechanisms developed by pathogens to evade the IFN-γ response, which could contribute to the susceptibility to the infections by major virulent agents, such as Mycobacterium tuberculosis.
As a conclusion, Kong et al. have found novel genetic mutations associated to an increased susceptibility to mycobacterial infections.
Furthermore, authors revealed new insights relative to the IFN-γ machinery as well as the crosstalk between DCs and T helper cells. These new findings can lead to novel research areas focused on the susceptibility to mycobacteria, which could contribute to a better design of vaccines and therapies for this pathogen.
